Analysis of the specificity and sensitivity of procalcitonin in relation to other markers of inflammation in critically ill patients;Analýza specificity a senzitivity prokalcitoninu ve srovnání s dalšími markery zánětu u kriticky nemocných

Anesteziologie a Intenzivni Medicina

Volumn 17, Issue 3, 2006, Pages 164-170

  Valenta, Jiří ^a,d   Jabor, A ^b,c   Brodska H ^a   Stach, Z ^a   Kazda, A ^a,b   Stritesky M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b IPVZ   (Czech Republic)

^c Oddeleni Klinicke Biochemie   (Czech Republic)

^d Klinika Anesteziologie a Resuscitace   (Czech Republic)

Author keywords

Acute phase reactants; C reactive protein; MODS; Procalcitonin; ROC analysis; SIRS; SOFA

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; MARKER; OROSOMUCOID; PREALBUMIN; PROCALCITONIN;

APACHE; AREA UNDER THE CURVE; ARTICLE; BLOOD CULTURE; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; HEALTH STATUS; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; KRUSKAL WALLIS TEST; LEUKOCYTE COUNT; MICROBIOLOGICAL EXAMINATION; PROSPECTIVE STUDY; RANK SUM TEST; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVOR; THROMBOCYTE COUNT;

EID: 53649083219     PISSN: 12142158     EISSN: 18054412     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Maruna, P. Prokalcitonin. Praha : Triton 2003, 140 s. ISBN 80-7254-410-1.
2. Kazda, A. et al. Prokalcitonin u kriticky nemocnych. Klin. Biochem. Metab., 2005, roč. 13(34), č. 1, s. 4-9.
3. Simon, L. et al. Serum procalcitonin and C-reactive protein as markers of bacterial infection: a systemic review and meta-analysis. Clin. Infectious Dis., 2004, 39, p. 206-217.
4. Giamarellou, H. et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin. Microbiol. Infect, 2004, 10, p. 628-633.
5. Kazda, A. et al. Prokalcitonin u akutních pankreatitid a v septických stavech. Klin. Biochem. Metab., 2002, roč. 10 (31), č. 1, s. 32-37.
6. Chirouze, C. et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clinical Infection Dis., 2002, 35, p. 156-161.
7. Hájek, T. et al. Role prokalcitoninu ve sledování nemocných po kardiochirurgických výkonech. Rozhledy v chirurgii, 2004, 83, č. 7, s. 337-341.
8. Šimák, J. et al. Patofyziologie systé mové zánětlivé odpovědi. Anest. neodklad. Péče, 1995, roč. 6, č. 5, s. 165-168.
9. Bone, R. C. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992, 101, p. 1644-1655.
10. Bone R. C. et al. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest, 1992, 101, p. 1481-1483.
11. Erten, N. et al. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J. Chin. Med. Assoc., 2004, 67, p. 217-221.
12. Giamarellos-Bourboulis, E. J. et al.:Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clinical Infection Dis., 2001, 32, p. 1718-1725.